Abdulazeez Salawu Selected Research

Abdulazeez Salawu Research Topics

5	Neoplasms (Cancer) 10/2023 - 01/2020
4	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2012
3	Leiomyosarcoma 10/2023 - 01/2012
2	Disease Progression 10/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2018 - 07/2013
2	Liposarcoma 01/2018 - 10/2016
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Salivary Gland Neoplasms (Salivary Gland Cancer) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Mesothelioma 12/2020
1	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 10/2019
1	Genomic Instability 01/2018
1	Phlebitis 01/2014
1	Uveal melanoma 07/2013

2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2012
1	durvalumabIBA 10/2023
1	cediranib (AZD2171)IBA 10/2023
1	olaparibIBA 10/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	AntibodiesIBA 11/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	AfatinibIBA 01/2022
1	CytokinesIBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2018
1	Codon (Codons)IBA 07/2013
1	MitogensIBA 07/2013
1	Cyclin D1IBA 07/2013
1	ParaffinIBA 01/2012
1	OligonucleotidesIBA 01/2012
1	Formaldehyde (Formol)FDA Link 01/2012

4	Therapeutics 01/2023 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2021 - 10/2019
2	Radiotherapy 01/2021 - 10/2016
1	Immunotherapy 10/2023
1	Salvage Therapy 01/2023
1	Neoadjuvant Therapy 01/2021
1	Personal Protective Equipment 01/2020
1	Aftercare (After-Treatment) 10/2019
1	Cannula 01/2014
1	Intravenous Infusions 01/2014